Botanix Pharmaceuticals Limited BXPHF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 26.98% | 27.10% | -8.25% | -4.94% | -542.17% |
| Total Depreciation and Amortization | 9.32% | 9.13% | 6.86% | 3.60% | 1,639.34% |
| Total Amortization of Deferred Charges | -46.79% | -46.88% | -- | -- | -- |
| Total Other Non-Cash Items | -63.26% | -63.32% | 321.25% | 314.48% | 671.09% |
| Change in Net Operating Assets | 53.66% | 53.74% | -- | -- | -1,633.68% |
| Cash from Operations | 20.78% | 20.91% | 0.24% | 3.29% | -969.00% |
| Capital Expenditure | 101.28% | 101.30% | 97.63% | 97.69% | -148.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 42.02% | 43.82% | 100.00% |
| Cash from Investing | 118.50% | 118.40% | 47.92% | 49.49% | 94.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2,049.77% | -2,049.77% | -234.42% | -234.42% | -- |
| Issuance of Common Stock | 12.50% | 12.50% | -95.45% | -95.45% | -44.84% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 7.74% | 7.74% | -- | -- | 20.82% |
| Cash from Financing | -33.24% | -33.34% | -742.45% | -723.27% | -7.60% |
| Foreign Exchange rate Adjustments | 196.25% | 196.17% | -160.98% | -159.13% | -182.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -66.35% | -66.41% | -8.82% | -5.50% | -73.66% |